Barkworth

RTI Trying to get Back on Track

شراء
Barkworth تم تحديثه   
TSXV:RTI   None
Radient just recently published its results for Q1. With the newly granted license, this company can now, for the first time, start to generate revenue. Looking at its financials, I think they are in an extremely good position. The $1 is a traditionally tough resistance for penny stocks to break. It is at this very level that RTI is trying to break back into its organic growth channel. It has been undervalued for some time, and I regret that I didn't discover them sooner.

This could be one that got away. It is flying under the rader, which is strange, because its patented extraction technology is potentially disruptive. Where Valens takes hours to extract, Radient takes minutes, and with much larger quantities at a time. In addition, the purity/potency of the CBD oil they extract, is higher/better.

Valens is currently trading at $3.10. I think that, right now, RTI is still in its buying zone, and we may be looking at a 500% to 1.000% upside, as soon as they start to post earnings and profits. Make no mistake. Aurora owns a decent stake, but Radient has the capacity to extract more than 10 times what Aurora can produce when they optimise capacity. Radient also installed its tech in Madrid.

I'm expecting a lot from Radient, but not tomorrow. If you buy in now, you'll have to go long. I am long RTI.
تعليق:
PS. If you want to study their financials, you'll have to download them from Radient's website. The numbers here on Tradingview are not up to date with its Q1 results.

🅱🄰🆁🅺🆆🄾🆁🆃🅷
إخلاء المسؤولية

لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.